You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Favipiravir

Showing 1 - 25 of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CCHF Trial (Favipiravir, Ribavirin)

Not yet recruiting
  • CCHF
  • (no location specified)
Jul 7, 2023

Infectious Disease, Pharmacology Trial in Paris (favipiravir, Placebo)

Not yet recruiting
  • Infectious Disease
  • Pharmacology
  • favipiravir
  • Placebo
  • Paris, France
    University Hospital Bichat - Claude Bernard
Aug 31, 2023

COVID-19 Trial in London (Favipiravir, Lopinavir/ Ritonavir, Favipiravir Placebo)

Completed
  • COVID-19
  • Favipiravir
  • +3 more
  • London, United Kingdom
  • +1 more
Dec 12, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial (Favipiravir HU 200 mg hard capsules, Placebo HU)

Terminated
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • Favipiravir HU 200 mg hard capsules
  • Placebo HU
  • Szeged, Hungary
    University of Szeged - Internal Medicine
Nov 4, 2022

Sars-CoV2, COVID-19 Trial in Stanford (Favipiravir, Placebo, Standard of care treatment)

Completed
Has Results
  • Sars-CoV2
  • COVID-19
  • Favipiravir
  • +2 more
  • Stanford, California
    Stanford University
Jul 6, 2022

SARS-CoV-2 Infection Trial in Hungary (Favipiravir)

Completed
  • SARS-CoV-2 Infection
  • Favipiravir
  • Budapest, Hungary
  • +4 more
Oct 30, 2022

COVID-19 Trial in Mexico City (Maraviroc + Currently used therapy, Curently used therapy for COVID-19 non-critical patients,

Terminated
  • COVID-19
  • Maraviroc + Currently used therapy
  • +3 more
  • Mexico City, Cdmx, Mexico
    Hospital General de México "Dr. Eduardo Liceaga"
May 31, 2022

OBSERVATIONAL STUDY OF COMPARISON EFFECTIVITY BETWEEN REMDESIVIR

Completed
  • Duration of Hospitalization
  • Clinical Manifestation of COVID-19
  • Surabaya, East Java, Indonesia
    Gotong Royong Surabaya Hospital
Jan 23, 2022

Moderate to Severe COVID-19 Trial in Shanghai, Tashkent (JT001, JT001 , Favipiravir)

Not yet recruiting
  • Moderate to Severe COVID-19
  • Shanghai, Shanghai, China
  • +1 more
Mar 14, 2022

Covid19 Trial in Kuwait City (AVIGAN, Placebo Comparator)

Terminated
Has Results
  • Covid19
  • Kuwait City, Kuwait
  • +1 more
Mar 17, 2022

COVID-19 Trial in United States (Favipiravir, Standard of Care)

Completed
Has Results
  • COVID-19
  • Favipiravir
  • Standard of Care
  • Scottsdale, Arizona
  • +7 more
Mar 25, 2022

COVID-19 Trial in Russian Federation (Favipiravir, Remdesivir)

Completed
  • COVID-19
  • Ivanovo, Russian Federation
  • +5 more
Jan 7, 2022

Covid19 Trial in George Town (Favipiravir)

Completed
  • Covid19
  • Favipiravir
  • George Town, Pulau Pinang, Malaysia
    Penang General Hospital
Nov 15, 2021

COVID-19 Trial in Saudi Arabia (Favipiravir, Placebo)

Completed
  • COVID-19
  • Favipiravir
  • Placebo
  • Al Madinah, Saudi Arabia
  • +6 more
Nov 4, 2021

Covid19 Trial in Ciudad de Mexico (Favipiravir, Nitazoxanide, Nitazoxanide Placebo)

Recruiting
  • Covid19
  • Favipiravir
  • +2 more
  • Ciudad de Mexico, Azcapotzalco, Mexico
    Hospital de Infectología "Daniel Méndez Hernández" del Centro Mé
Oct 18, 2021

Covid19 Trial in Manila (Favipiravir + Standard of Care, Standard of Care)

Recruiting
  • Covid19
  • Favipiravir + Standard of Care
  • Standard of Care
  • Manila, National Capital Region, Philippines
    Dr. Regina Berba
Aug 19, 2021

Infectious Disease, SARS-CoV Infection, Covid19 Trial in Magelang, Semarang, Jakarta (Favipiravir, Azithromycin)

Recruiting
  • Infectious Disease
  • +2 more
  • Magelang, Central Java, Indonesia
  • +2 more
Oct 3, 2021

SARS-CoV 2, COVID-19 Trial in Manama (Hydroxychloroquine, Favipiravir, Routine care for COVID-19 patients)

Completed
  • SARS-CoV 2
  • COVID-19
  • Manama, Bahrain
    Royal College of Surgeons in Ireland - Bahrain
Oct 25, 2021

Coronavirus Infection Trial in Brazil, Mexico, United Kingdom (Favipiravir, Standard of care management)

Completed
  • Coronavirus Infection
  • Favipiravir
  • Standard of care management
  • Porto Alegre, Brazil
  • +5 more
Nov 17, 2021

Covid19 Trial in Ankara, Istanbul (Hydroxychloroquine, Favipiravir, Favipiravir + Hydroxychloroquine)

Completed
  • Covid19
  • Ankara, Turkey
  • +5 more
Jul 26, 2021

Influenza, Influenza, Human Trial in Bangkok (Drug: Oseltamivir, Drug: Favipiravir, Drug: Zanamivir)

Not yet recruiting
  • Influenza
  • Influenza, Human
  • Drug: Oseltamivir
  • +6 more
  • Bangkok, Thailand
    Faculty of Tropical Medicine, Mahidol University
Jan 30, 2023

COVID19 Trial in Saudi Arabia (Favipiravir and Hydroxychloroquine)

Completed
  • COVID19
  • Favipiravir and Hydroxychloroquine
  • Hasa, Eastern Region, Saudi Arabia
  • +7 more
Aug 19, 2021

COVID-19, SARS-CoV-2 Trial in Toronto (Favipiravir, Favipiravir Placebo)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • Favipiravir
  • Favipiravir Placebo
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Aug 11, 2021

Antiviral Drugs on the Treatment of SARS-CoV-2

Recruiting
  • Complication of Medical Care
  • Pneumonia, Viral
  • Nur-Sultan, Kazakhstan
  • +1 more
Jul 19, 2022

SARS-COV-2 Infections, COVID-19 Trial in Bangkok (Oral)

Completed
  • SARS-COV-2 Infections
  • COVID-19
  • Bangkok, Thailand
    Assistant Professor Subsai Kongsaengdao
Aug 28, 2021